Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia

scientific article

Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1037848838
P356DOI10.1186/1472-6963-8-196
P932PMC publication ID2562379
P698PubMed publication ID18816393
P5875ResearchGate publication ID23282111

P2093author name stringSusan E Tett
Nadia Barozzi
P2860cites workTime dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approachQ24673561
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control studyQ24803974
Underutilization of preventive strategies in patients receiving NSAIDsQ28165863
Nonsteroidal anti-inflammatory drug prescribing: past, present, and futureQ28175506
Understanding NSAIDs: from aspirin to COX-2Q28186635
Risk of Upper Gastrointestinal Injury and Events in Patients Treated With Cyclooxygenase (COX)-1/COX-2 Nonsteroidal Antiinflammatory Drugs (NSAIDs), COX-2 Selective NSAIDs, and Gastroprotective Cotherapy: An Appraisal of the LiteratureQ28200737
Auditing prescription practice using explicit criteria and computerized drug benefit claims dataQ32129240
The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs: a review of the literatureQ34034067
Maximizing the benefit--minimizing the risk: the developing role of radiographers in performing intravenous injectionsQ34340658
Personal formularies. An index of prescribing quality?Q34363667
Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological studyQ34444119
Gastrointestinal effects of NSAIDs and coxibsQ35072859
Key questions concerning paracetamol and NSAIDs for osteoarthritis.Q35551913
The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in ScotlandQ35827761
Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular riskQ36464651
Prescribing of COX-2 inhibitors in Germany after safety warnings and market withdrawalsQ36636548
Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitorsQ39711512
Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitorsQ39721735
Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.Q40418551
Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern IrelandQ40518784
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners.Q44617592
Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland.Q50724553
Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory DrugsQ67903664
Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory CommitteeQ71094719
Recent changes in the profile of prescription NSAID use in AustraliaQ73692458
Drug utilization 90%--a simple method for assessing the quality of drug prescribingQ74648667
What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?Q80629745
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectAustraliaQ408
paracetamolQ57055
P304page(s)196
P577publication date2008-09-24
P1433published inBMC Health Services ResearchQ4835946
P1476titleNon-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia
P478volume8

Reverse relations

cites work (P2860)
Q35834675Actions following adverse drug events - how do these influence uptake and utilisation of newer and/or similar medications?
Q33953093Cause for concern in the use of non-steroidal anti-inflammatory medications in the community--a population-based study
Q45219814The increasing rates of acute interstitial nephritis in Australia: a single centre case series.
Q43219102Trends in the non-steroidal anti-inflammatory drug market in six Central-Eastern European countries based on retail information

Search more.